Nanotechnology in the Treatment and Diagnosis of Cancer: Opportunities and Challenges
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Nanoscience".
Deadline for manuscript submissions: closed (30 May 2024) | Viewed by 547
Special Issue Editor
2. World Institute for Family Health, University of Kalisz, Nowy Swiat 4, 62-800 Kalisz, Poland
Interests: nanotoxicology; impact of nanoparticles on cancer; pesticides toxicity; environmental health
Special Issue Information
Dear Colleagues,
According to the latest available data prepared by the World Health Organization, cancer caused almost 10 million deaths in 2020, and at the same time almost 20 million new cases were identified. However, many cancers can be cured if detected and treated early enough. Advances in nanotechnology over recent decades have provided new hope in cancer treatment. Nanomaterials are successfully used at the diagnostic stage, supporting various imaging techniques. Additionally, a number of nanocarriers have been developed for the transport of cytostatic drugs. Moreover, nanotechnology has been used in many forms of anticancer therapy. The use of nanomaterials per se as active substances with direct anticancer effects is also widely discussed.
However, the number of nanomedicines approved for use has not increased significantly over the years. Scientists encounter numerous challenges when trying to transfer the results of in vitro/in vivo research to clinical conditions. There is also an increasing discussion on the scientific forum about the broad spectrum of toxicity of nanomaterials, including their potential procarcinogenic and prometastatic effects.
The aim of this Special Issue is to create a space in which you will be able to share with a wide audience the results of research relating primarily to the use of nanotechnology in the diagnosis and treatment of cancer, but also focusing on the assessment of the safety of used nanomaterials.
This Special Issue is supervised by Prof. Dr. Lucyna Kapka-Skrzypczak and assisted by our Topical Advisory Panel Member, Dr. Magdalena Matysiak-Kucharek (Institute of Rural Health).
Prof. Dr. Lucyna Kapka-Skrzypczak
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nanomaterials
- cancer
- nanomedicine
- biological effects
- cancer therapy
- metastasis
